Correlation Between CVS Health and Viridian Therapeutics

Can any of the company-specific risk be diversified away by investing in both CVS Health and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS Health and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CVS Health Corp and Viridian Therapeutics, you can compare the effects of market volatilities on CVS Health and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS Health with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS Health and Viridian Therapeutics.

Diversification Opportunities for CVS Health and Viridian Therapeutics

0.63

Correlation Coefficient

CVS Health  Viridian Therapeutics

Poor diversification

The 3 months correlation between CVS and Viridian is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health Corp and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and CVS Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS Health Corp are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of CVS Health i.e., CVS Health and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between CVS Health and Viridian Therapeutics

Assuming the 90 days trading horizon CVS Health Corp is expected to under-perform the Viridian Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, CVS Health Corp is 2.08 times less risky than Viridian Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Viridian Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  3,723  in Viridian Therapeutics on October 5, 2024 and sell it today you would lose (1,760) from holding Viridian Therapeutics or give up 47.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	93.94%
Values	Daily Returns

CVS Health Corp  vs.  Viridian Therapeutics

CVS Health Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CVS Health Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Viridian Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with CVS Health and Viridian Therapeutics

The main advantage of trading using opposite CVS Health and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS Health position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.

The idea behind CVS Health Corp and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.